Galmed Reports Positive Colospan Tissue Assessment Study
Tel Aviv, Israel, August 19, 2026 Galmed Pharmaceuticals announced successful first-in-human proof-of-concept results for a novel intraoperative tissue assessment...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Tel Aviv, Israel, August 19, 2026 Galmed Pharmaceuticals announced successful first-in-human proof-of-concept results for a novel intraoperative tissue assessment...
SUNNYVALE, Calif., May 13, 2026 Cepheid, a Danaher company, announced that it has received CE marking under the European...
NEW YORK, May 13, 2026 Pfizer has received European Commission approval for HYMPAVZI® (marstacimab) for the treatment of adults...
JERSEY CITY, N.J. and OR YEHUDA, Israel, May 11, 2026 Exero Medical has announced positive pivotal clinical study results...
